ILR, interleukin receptor
GGT is present in several organs, including the kidneys, pancreas, and heart, which is why an isolated elevation can require a wider review instead of an automatic assumption of liver disease (medical policy summary on GGT testing in adults)
We believe that the protective effect of T on the CV system provides clinicians with the opportunity to utilize this approach for secondary prevention for hypogonadal men with a history of CV events, explained corresponding author Abdulmaged M
The cancelled 2015 Phase I trial (NCT02637284) was almost certainly abandoned for this reason rather than buried by a regulator
Patient-centred approaches for the management of unpleasant symptoms in kidney disease
Schulz JB, Lindenau J, Seyfried J, Dichgans J